BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1820929)

  • 1. Application of non parametric methods to pharmacokinetic models of the Michaelis-Menten type.
    Pereira LM; Maya MT; Morais JA
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():497-500. PubMed ID: 1820929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel.
    Dansirikul C; Choi M; Duffull SB
    Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics.
    Marsh RE; Riauka TA; McQuarrie SA
    J Pharm Pharm Sci; 2007; 10(2):168-79. PubMed ID: 17706176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved rearrangement of the integrated Michaelis-Menten equation for calculating in vivo kinetics of transport and metabolism.
    Russell RW; Drane JW
    J Dairy Sci; 1992 Dec; 75(12):3455-64. PubMed ID: 1474212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
    Terziivanov D; Atanasova I; Dimitrova V
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization algorithms and weighting factors for analysis of dynamic PET studies.
    Yaqub M; Boellaard R; Kropholler MA; Lammertsma AA
    Phys Med Biol; 2006 Sep; 51(17):4217-32. PubMed ID: 16912378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of direct search optimization for pharmacokinetic parameter estimation.
    Khorasheh F; Sattari S; Gerayeli A; Ahmadi AM
    J Pharm Pharm Sci; 1999; 2(3):92-8. PubMed ID: 10953255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of procedures for determining Michaelis-Menten parameters together with their standard deviations using simulated measurement series].
    Hoppe H; Cumme GA
    Acta Biol Med Ger; 1978; 37(8):1177-84. PubMed ID: 749454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TopFit: a PC-based pharmacokinetic/pharmacodynamic data analysis program.
    Tanswell P; Koup J
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):514-20. PubMed ID: 8262691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.
    Wyska E; Szymura-Oleksiak J; Pekala E; Obruśnik A
    J Pharm Pharmacol; 2007 Apr; 59(4):495-501. PubMed ID: 17430632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Windows based general PBPK/PD modeling software.
    Luecke RH; Pearce BA; Wosilait WD; Doerge DR; Slikker W; Young JF
    Comput Biol Med; 2008 Sep; 38(9):962-78. PubMed ID: 18657803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of MS-DOS and Macintosh pharmacokinetic analysis programs using a two-compartment, two-infusion dosing scheme.
    Hampton EM; Hrdlicka K; Bourne DW
    Clin Pharm; 1991 Mar; 10(3):206-9. PubMed ID: 2040127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of enzyme kinetic parameters based on statistical learning.
    Borger S; Liebermeister W; Klipp E
    Genome Inform; 2006; 17(1):80-7. PubMed ID: 17503358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation for population analysis of Michaelis-Menten elimination kinetics.
    Hashimoto Y; Koue T; Otsuki Y; Yasuhara M; Hori R; Inui K
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):205-16. PubMed ID: 8719237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlinear least-squares regression analysis by a simplex method using differential equations containing Michaelis-Menten type rate constants.
    Murata K; Kohno K
    Biopharm Drug Dispos; 1989; 10(1):25-34. PubMed ID: 2923959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.